Encephalomyelitis Global Clinical Trials Review, H2, 2017

Price :
Published : Aug-2017
No. of Pages : 62

Encephalomyelitis Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Encephalomyelitis Global Clinical Trials Review, H2, 2017” provides an overview of Encephalomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Encephalomyelitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Anthem Inc (ANTM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for in......

HCA Healthcare Inc (HCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and ancillary health care services; diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. HCA operates its facilities in various states of the US and in England, the UK. HCA is headquartered in Nashville, Tennessee, the US. ......

ethris GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ethris GmbH (Ethris) is a biotechnology company that develops and manufactures therapeutics. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris' magnetovax is a platform for personalized tumor vaccines localized and activated in tumors by magnetic fields and transports nucleic acid agents. The company's drug candidates include ETH-CFTR, ETH-CCDC40, ETH-CCNO and ETH-OTC. It partners with academic and medical institutions in Germany and abroad for its research and development activities. Ethris is headquartered in Planegg, Germany. ethris GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acq......

Klox Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Klox Technologies Inc (Klox Technologies) is a specialty pharmaceutical company, which focuses on the development and commercialization of a proprietary BioPhotonic technology platform. Its pipeline portfolio includes non-invasive wound care treatment solutions, dermatological treatment solutions and adjunct treatment to scaling and root planning. The company's technology platform is a non-invasive, pathology-specific topical treatment platform which uses the power of light and photo-activated, oxygen-rich gel formulations to treat a wide range of skin and soft tissue disorders. The company carries out research in dermatology, wound care, oral care and cosmetology. The company has collaborations with LEO Pharma A/S to commercialize its technology platform in the field of dermato......

MedDay SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for brain metabolism to treat diseases of the nervous system. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism. Its pipeline products include molecules such as MD1003, MD1103 and MD1105. MedDay develops products for neurological and psychiatric diseases such as progressive multiple sclerosis, autism spectrum disorders and Alzheimer's disease. The company utilizes its SPECMET research platforms to discover additional pipeline assets. Its SPECMET metabolomics platform identifies therapeutic targets through cerebrospinal fluid metabolomic analysis. The company operates in Germany and the UK. MedDay is headquartered in Paris, France. MedDay SA - Pharmaceu......

Genoptix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Genoptix Inc (Genoptix) is a healthcare services provider that offers diagnostic solutions. The center offers oncology diagnostics and informatics services. It provides biopharma and healthcare laboratory, discovery, drug development, care and cost development; diagnostics, and patient services. Genoptix's biopharma services include clinical trial testing, custom assay development, and companion diagnostic services. The center's compass takes the guesswork out of oncological bone marrow and blood workups. It offers patient assessment services for colorectal, breast, lung, blood, melanoma and skin care; and general disease applications. The center provides its oncology diagnostic services and personalized and comprehensive solutions to community-based hematologists and oncologist......

The Hospital for Sick Children – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary The Hospital for Sick Children (SickKids) is a healthcare service provider that offers children care services. The hospital offers programs and services including resources, tele-medicine, accommodations, child life, creative arts therapy, child and family-centered care; health records inquiries, and others. It provides epilepsy classroom, paediatric advanced care team, the play park, paediatric laboratory medicine, tele-link mental health program and resource navigation programs. SickKids offers services across wide range of clinical specialties including cardiology, clinical pharmacology and toxicology, endocrinology, infectious diseases and neurology among others. It also provides development of accessible, comprehensive and sustainable child health systems. The hospital oper......

Litha Healthcare Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. The company operates through its three divisions such as pharmaceuticals, medical devices and biotechnology. Its pharma division offers generic, originator and complementary medicines in the therapeutic areas of oncology, gastroenterology, neurology, urology and dermatology, among others. Litha Healthcare provides medical devices, consumables and equipment serving the therapeutic areas of ophthalmology, orthopaedics and sports medicine, surgery and others. Litha Healthcare's biotechnology di......

WellSpring Pharmaceutical Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary WellSpring Pharmaceutical Corp (WellSpring Pharma) is a healthcare products provider that offers medicinal products. The company develops over the counter consumer pharmaceuticals and new prescription drugs. Its products include bonine, gelusil, emetrol, bactine, micatin, glaxal base, FDS, barriere silicone skin cream, K-LYTE potassium supplement, and others. WellSpring Pharma's products are provided in the dosage forms of tablets, liquids and semi-solids. The company's services include WPC outsourcing, and patient assistance. It also provides contract manufacturing services to other pharmaceutical companies. The company operates through its manufacturing plant in Oakville, Ontario, Canada. WellSpring Pharma is headquartered in Sarasota, Florida, the US. WellSpring Pharmaceut......

Presidio Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company's products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, faldaprevir and non-nucleoside inhibitor. Presidio's lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride has completed phase 1 clinical studies in both healthy volunteers and HCV patients. Its second pan-genotypic HCV inhibitor PPI-383 is a NS5B non-nucleoside inhibitor currently being evaluated in phase 1 studies. The company also has an extensive intellectual property portfolio for its HCV programs. Presidio is headquartered in San Francisco, California, the US. Presidio Pharm......